{"id":4671,"date":"2025-11-14T17:36:35","date_gmt":"2025-11-14T15:36:35","guid":{"rendered":"https:\/\/staging.iasispharma.com\/en\/?p=4671"},"modified":"2026-10-30T13:29:42","modified_gmt":"2026-10-30T11:29:42","slug":"%cf%83%cf%85%ce%bc%ce%bc%ce%b5%cf%84%ce%bf%cf%87%ce%b7-%cf%84%ce%b7%cf%83-iasis-pharma-25o-%cf%80%ce%b1%ce%bd%ce%b5%ce%bb%ce%bb%ce%b7%ce%bd%ce%b9%ce%bf-%cf%83%cf%85%ce%bd%ce%b5%ce%b4%cf%81%ce%b9","status":"publish","type":"post","link":"https:\/\/iasispharma.com\/en\/all-articles\/%cf%83%cf%85%ce%bc%ce%bc%ce%b5%cf%84%ce%bf%cf%87%ce%b7-%cf%84%ce%b7%cf%83-iasis-pharma-25o-%cf%80%ce%b1%ce%bd%ce%b5%ce%bb%ce%bb%ce%b7%ce%bd%ce%b9%ce%bf-%cf%83%cf%85%ce%bd%ce%b5%ce%b4%cf%81%ce%b9\/","title":{"rendered":"PARTICIPATION OF IASIS PHARMA IN THE  \u201c25th PANHELLENIC CONGRESS OF HYPERTENSION\u201d"},"content":{"rendered":"<p><strong>06\/11 \u2013 08\/11 2025,<\/strong><\/p>\n<p><strong>Makedonia Palace, Thessaloniki<\/strong><\/p>\n<p><strong><b>IASIS PHARMA<\/b><\/strong>\u00a0participated in the\u00a0<strong><b>\u201c25<\/b><\/strong><strong><sup><b>th<\/b><\/sup><\/strong><strong><b>\u00a0PANHELLENIC CONGRESS OF HYPERTENSION\u201d<\/b><\/strong>\u00a0which was held from\u00a0<strong><b>06\/11 <\/b><\/strong>to<strong><b>\u00a008\/11 2025,<\/b><\/strong>\u00a0at\u00a0the <strong><b>Makedonia Palace<\/b><\/strong>\u00a0<strong><b>Hotel\/Thessaloniki<\/b><\/strong>.<\/p>\n<p>The conference was organized by the\u00a0<strong><b>Hellenic Society of Hypertension (HSH).<\/b><\/strong><\/p>\n<p><strong><b>IASIS PHARMA<\/b><\/strong>\u00a0presented at its exhibition stand the following products:<\/p>\n<ul>\n<li><strong>RosuZet<sup>\u00ae<\/sup><\/strong>:\u00a0<strong><b>New Product Launching<\/b><\/strong>. Fixed-dose combination of\u00a0<strong><b>Rosuvastatin &amp; Ezetimibe<\/b><\/strong>, in a single dosage form, in packages of 30 f.c. tabs available in the full spectrum of strengths:\u00a05 \/ 10mg, 10 \/ 10mg, 20 \/ 10mg, 40 \/ 10mg<\/li>\n<li><strong>Rami<\/strong><strong>\u2013<\/strong><strong>Amlo<sup>\u00ae<\/sup><\/strong><strong>:\u00a0<\/strong>the original fixed dose combination of angiotensin-converting enzyme inhibitors with calcium channel blockers. Therapeutic indication, substitution therapy in patients whose blood pressure is adequately controlled with ramipril and amlodipine simultaneously at the same dose level. (Box of 28 caps, Ramipril \/ Amlodipine: 5mg \/ 5mg, 5mg \/ 10mg, 10mg \/ 5mg, 10mg \/ 10mg).<\/li>\n<li><strong>Rami<\/strong><strong>\u2013<\/strong><strong>Amlo\u00a0plus<sup>\u00ae<\/sup><\/strong><strong>:<\/strong>\u00a0the original, fixed dose combination of Ramipril \u2013 Amlodipine \u2013 Hydrochlorothiazide, indicated for the treatment of Hypertension. (Box of 30 caps, Ramipril \/ Amlodipine \/ Hydrochlorothiazide: 5 mg \/ 5 mg \/ 12,5 mg, 5 mg \/ 5 mg \/ 25 mg, 10 mg \/ 5 mg \/ 25 mg, 10 mg \/ 10 mg \/ 25 mg).<\/li>\n<li><strong>Licepler<sup>\u00ae<\/sup><\/strong>: Licepler is specifically indicated for the reduction of risk of cardiovascular death in people with heart failure and left ventricular dysfunction \u226440% after a recent acute myocardial infarction, in combination with standard therapies and as treatment against hypertension. (Box of 30 tabs at 25mg &amp; 50mg).<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" class=\"wp-image-4662 aligncenter\" src=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2025\/11\/YPERTASI-25-STAND-copy.png\" alt=\"Iasis Pharma Stand_Hypertension_2025\" width=\"511\" height=\"678\" srcset=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2025\/11\/YPERTASI-25-STAND-copy-120x159.png 120w, https:\/\/iasispharma.com\/wp-content\/uploads\/2025\/11\/YPERTASI-25-STAND-copy-200x265.png 200w, https:\/\/iasispharma.com\/wp-content\/uploads\/2025\/11\/YPERTASI-25-STAND-copy-226x300.png 226w, https:\/\/iasispharma.com\/wp-content\/uploads\/2025\/11\/YPERTASI-25-STAND-copy-400x531.png 400w, https:\/\/iasispharma.com\/wp-content\/uploads\/2025\/11\/YPERTASI-25-STAND-copy-500x664.png 500w, https:\/\/iasispharma.com\/wp-content\/uploads\/2025\/11\/YPERTASI-25-STAND-copy-600x796.png 600w, https:\/\/iasispharma.com\/wp-content\/uploads\/2025\/11\/YPERTASI-25-STAND-copy.png 605w\" sizes=\"(max-width: 511px) 100vw, 511px\" \/><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>06\/11 \u2013 08\/11 2025, Makedonia Palace, Thessaloniki IASIS PHARMA\u00a0participated in the\u00a0\u201c25th\u00a0PANHELLENIC CONGRESS OF HYPERTENSION\u201d\u00a0which was held from\u00a006\/11 to\u00a008\/11 2025,\u00a0at\u00a0the Makedonia Palace\u00a0Hotel\/Thessaloniki. The conference was organized by the\u00a0Hellenic Society of Hypertension (HSH). IASIS PHARMA\u00a0presented at its exhibition stand the following products: RosuZet\u00ae:\u00a0New Product Launching. Fixed-dose combination of\u00a0Rosuvastatin &amp; Ezetimibe, in a single dosage form, in packages  [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":true,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[33,157,204],"tags":[],"class_list":["post-4671","post","type-post","status-publish","format-standard","hentry","category-all-articles","category-press-room-en","category-conferences"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7HJeP-1dl","jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4671","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/comments?post=4671"}],"version-history":[{"count":2,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4671\/revisions"}],"predecessor-version":[{"id":4673,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/4671\/revisions\/4673"}],"wp:attachment":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/media?parent=4671"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/categories?post=4671"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/tags?post=4671"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}